SG Americas Securities LLC Takes Position in Merit Medical Systems, Inc. $MMSI

SG Americas Securities LLC purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 17,433 shares of the medical instruments supplier’s stock, valued at approximately $1,537,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Salomon & Ludwin LLC purchased a new position in shares of Merit Medical Systems during the 3rd quarter worth approximately $37,000. Danske Bank A S purchased a new position in shares of Merit Medical Systems in the 3rd quarter valued at approximately $42,000. Quarry LP boosted its position in shares of Merit Medical Systems by 185.9% during the third quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after purchasing an additional 342 shares in the last quarter. First Horizon Corp purchased a new stake in Merit Medical Systems in the third quarter worth $78,000. Finally, EverSource Wealth Advisors LLC grew its stake in Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock worth $86,000 after purchasing an additional 813 shares during the period. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MMSI has been the subject of several recent research reports. BTIG Research assumed coverage on Merit Medical Systems in a research report on Friday, February 6th. They set a “buy” rating and a $107.00 price objective for the company. Barrington Research upped their target price on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Canaccord Genuity Group increased their price target on shares of Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Wall Street Zen lowered shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Finally, Wells Fargo & Company cut shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $95.00 to $78.00 in a report on Thursday, February 26th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $101.25.

Merit Medical Systems Stock Up 0.2%

Shares of Merit Medical Systems stock opened at $67.81 on Tuesday. The company has a 50-day simple moving average of $75.13 and a two-hundred day simple moving average of $81.47. The stock has a market capitalization of $4.04 billion, a PE ratio of 31.99, a price-to-earnings-growth ratio of 1.95 and a beta of 0.64. Merit Medical Systems, Inc. has a 52-week low of $66.34 and a 52-week high of $100.19. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The company had revenue of $393.94 million during the quarter, compared to the consensus estimate of $390.77 million. During the same quarter last year, the firm earned $0.93 earnings per share. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, analysts anticipate that Merit Medical Systems, Inc. will post 3.37 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.